With Axogen Stock Sliding, Have You Assessed The Risk?
Axogen (AXGN) stock is down 7.6% in a day. The recent slide reflects renewed concerns around negative earnings and insider selling, but sharp drops like this often raise a tougher question: is the weakness temporary, or a sign of deeper cracks in the story?
Before judging its downturn reslience, let’s look at where Axogen stands today.
- Size: Axogen is a $1.4 Bil company with $215 Mil in revenue currently trading at $30.79.
- Fundamentals: Last 12 month revenue growth of 18.7% and operating margin of 1.8%.
- Liquidity: Has Debt to Equity ratio of 0.08 and Cash to Assets ratio of 0.17
- Valuation: Axogen stock is currently trading at P/E multiple of -395.5 and P/EBIT multiple of 145.8
These metrics point to a Moderate operational performance, alongside Moderate valuation – making the stock Fairly Priced. For details, see Buy or Sell AXGN Stock
That brings us to the key consideration for investors worried about this fall: how resilient is AXGN stock if markets turn south? This is where our downturn resilience framework comes in. Suppose AXGN stock falls another 20-30% to $22 – can investors comfortably hold on? Turns out, the stock has fared much worse than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.
- Beyond Price Action: Does DG Offer Genuine Diversification?
- Kyndryl Stock: Strong Cash Flow Poised for a Re-Rating?
- S&P Global Stock Pays Out $29 Bil – Investors Take Note
- General Motors Stock Hands $29 Bil Back – Worth a Look?
- Coinbase Global Stock Testing Price Floor – Buy Now?
- Intuit Stock Near Crucial Support – Buy Signal?
2022 Inflation Shock
- AXGN stock fell 84.6% from a high of $23.50 on 7 May 2021 to $3.61 on 1 November 2023 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 4 November 2025
- Since then, the stock increased to a high of $33.32 on 7 December 2025 , and currently trades at $30.79
| AXGN | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -84.6% | -25.4% |
| Time to Full Recovery | 734 days | 464 days |
2020 Covid Pandemic
- AXGN stock fell 58.9% from a high of $17.89 on 1 January 2020 to $7.34 on 16 April 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 28 December 2020
| AXGN | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -58.9% | -33.9% |
| Time to Full Recovery | 256 days | 148 days |
2018 Correction
- AXGN stock fell 80.0% from a high of $55.90 on 23 July 2018 to $11.18 on 9 October 2019 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- The stock is yet to recover to its pre-Crisis high
| AXGN | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -80.0% | -19.8% |
| Time to Full Recovery | Not Fully Recovered | 120 days |
2008 Global Financial Crisis
- AXGN stock fell 82.7% from a high of $7.50 on 5 July 2007 to $1.30 on 20 December 2007 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 8 July 2016
| AXGN | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -82.7% | -56.8% |
| Time to Full Recovery | 3123 days | 1480 days |
Feeling jittery about AXGN stock? Consider portfolio approach.
Portfolios Over Individual Stock Picks
Individual stocks can soar or tank but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside and mitigate the downside associated with any individual stock.
The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.